These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Use of visken in hypertension associated with ischemic heart disease and nutritional obesity]. Khomenko VL, Vasiuk IuA, Romashkin AV, Sivkov SI, Mel'nikov AIu, Buskin VD. Sov Med; 1990; (3):64-7. PubMed ID: 2195673 [No Abstract] [Full Text] [Related]
3. [Dose-related effect of the beta sympatholytic agent prindolol (Visken) on hemodynamics and contractility of the heart following experimental coronary occlusion]. Hübner H, Stephan K, Meesmann W. Verh Dtsch Ges Inn Med; 1975; 81():317-20. PubMed ID: 1229528 [No Abstract] [Full Text] [Related]
4. The haemodynamic effect of intravenous amiodarone in patients with preserved left ventricular function. Signy M, Turnbull P, Wilmshurst PT, Roskovec A, Coltart DJ. Br J Clin Pract Suppl; 1986 Apr; 44():139-46. PubMed ID: 3089253 [No Abstract] [Full Text] [Related]
10. [Effect of amiodarone on ventricular systolic time intervals in patients with coronary disease]. Markiewicz M, Wysokiński A, Rymar B, Wilkołaski J, Grzywa R, Wójcik J. Pol Tyg Lek; 1984 Jan 30; 39(5):143-6. PubMed ID: 6739364 [No Abstract] [Full Text] [Related]
11. [Hemodynamic changes induced by amiodarone in patients with ischemic heart disease]. Rizzon P, Biasco G, Brindicci G, Antonelli G, Miccoli A. Boll Soc Ital Cardiol; 1973 Jan 30; 18(3):226-31. PubMed ID: 4807062 [No Abstract] [Full Text] [Related]